Patent Assignment
Reel/Frame 071147/0260
Security Interest
Recorded: 2025-05-01
Pages: 63
Assignor
BIOHAVEN THERAPEUTICS LTD
Executed: 2025-04-28
Assignee
BEETLEJUICE SA LLC, AS PURCHASER AGENT
C/O OBERLAND CAPITAL MANAGEMENT, 1700 BROADWAY, 37TH FL, NEW, NEW YORK, 10019
Covered Properties
(61)
Prodrugs of Riluzole and Their Method of Use
Application:
62/127,684 →
Prodrugs of Riluzole and Their Method of Use
Application:
19/064,963 →
Publication:
US US20260091024A1
Prodrugs of Riluzole and Their Method of Use
Prodrugs of Riluzole and Their Method of Use
Application:
18/361,836 →
Publication:
US US20240091205A1
Prodrugs of Riluzole and Their Method of Use
Riluzole Prodrugs and Their Use
Riluzole Prodrugs and Their Use
Riluzole Prodrugs and Their Use
Riluzole Prodrugs and Their Use
Riluzole Prodrugs and Their Use
Riluzole Prodrugs and Their Use
Riluzole Prodrugs and Their Use
Riluzole Prodrugs and Their Use
Use of Glutamate Modulating Agents with Immunotherapies to Treat Cancer
Use of Riluzole, Riluzole Prodrugs or Riluzole Analogs with Immunotherapies to Treat Cancers
Application:
17/878,121 →
Publication:
US US20230310595A1
Use of Riluzole, Riluzole Prodrugs or Riluzole Analogs with Immunotherapies to Treat Cancers
Acyl Benzo[D]Thiazol-2-Amine and Their Methods of Use
Acyl Benzo[D]Thiazol-2-Amine and Their Methods of Use
Application:
18/766,482 →
Publication:
US US20240358685A1
Acyl Benzo[D]Thiazol-2-Amine and Their Methods of Use
Application:
62/373,091 →
Use of Riluzole Prodrugs to Treat Ataxias
Application:
62/584,856 →
Use of Riluzole Prodrugs to Treat Ataxias
Application:
62/717,948 →
Use of Riluzole Prodrugs to Treat Ataxias
Use of Riluzole Prodrugs to Treat Ataxias
Application:
18/353,850 →
Publication:
US US20230355592A1
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
Application:
62/701,814 →
Use of Riluzole Prodrugs to Treat Ataxias
Application:
16/762,165 →
Publication:
US US20210023061A1
Compositions and Methods for Treating Obsessive-Compulsive Disorder
Application:
17/923,587 →
Publication:
US US20230181541A1
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
Application:
63/138,669 →
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
Application:
18/261,419 →
Publication:
US US20240082340A1
Compositions and Methods for Treating Obsessive-Compulsive Disorder
Application:
63/043,681 →
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
Biohaven Provides Update on Phase 3 Clinical Trial Evaluating Troriluzole for Spinocerebellar Ataxia (Sca)
Application:
63/344,917 →
Methods of Treating Spinocerebellar Ataxias
Application:
18/867,416 →
Publication:
US US20260124183A1
Prodrugs of Riluzole and Their Method of Use
Application:
61/612,210 →
Prodrugs of Riluzole and Their Method of Use
Prodrugs of Riluzole and Their Method of Use
Prodrugs of Riluzole and Their Method of Use
Prodrugs of Riluzole and Their Method of Use
Prodrugs of Riluzole and Their Method of Use
Pro-Drugs of Riluzole and Their Method of Use for the Treatment for Amyotrophic Lateral Sclerosis
Application:
61/663,573 →
Pro-Drugs of Riluzole and Their Method of Use for the Treatment of Amyotrophic Lateral Sclerosis
Pro-Drugs of Riluzole and Their Method of Use for the Treatment of Amyotrophic Lateral Sclerosis
Combination Therapies Including Metal Channel Activators
Application:
63/403,911 →
Treatment of Glioblastoma with Prodrugs of Riluzole
Application:
63/355,631 →
Pro-Drugs of Riluzole and Their Method of Use for the Treatment of Amyotrophic Lateral Sclerosis
Methods of Treating Glioblastoma with Prodrugs of Riluzole
Application:
18/876,651 →
Publication:
US US20250375427A1
Use of Riluzole, Riluzole Prodrugs or Riluzole Analogs with Immunotherapies to Treat Cancers
Application:
62/339,433 →
Prodrugs Riluzole and Their Method of Use
PCT:
PCT/US2016/019773 ↗
Riluzole Prodrugs and Their Use
PCT:
PCT/US2016/019787 ↗
Use of Glutamate Modulating Agents with Immunotherapies to Treat Cancer
PCT:
PCT/US2017/033690 ↗
Use of Riluzole, Riluzole Prodrugs or Riluzole Analogs with Immunotherapies to Treat Cancers
PCT:
PCT/US2017/033688 ↗
Acyl Benzo[D]Thiazol-2-Amine and Their Methods of Use
PCT:
PCT/US2017/046184 ↗
Use of Riluzole Prodrugs to Treat Ataxias
PCT:
PCT/US2018/060232 ↗
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
PCT:
PCT/US2019/042718 ↗
Compositions and Methods for Treating Obsessive-Compulsive Disorder
PCT:
PCT/US2021/038789 ↗
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
PCT:
PCT/US2022/012660 ↗
Methods of Treating Spinocerebellar Ataxias
PCT:
PCT/US2023/067326 ↗
Combination Therapies Including Metal Channel Activators
PCT:
PCT/US2023/073504 ↗
Prodrugs of Riluzole and Their Method of Use
PCT:
PCT/US2013/032292 ↗
Pro-Drugs of Riluzole and Their Method of Use for the Treatment of Amyotrophic Lateral Sclerosis
PCT:
PCT/US2013/047315 ↗
Methods of Treating Glioblastoma with Prodrugs of Riluzole
PCT:
PCT/US2023/069038 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 13, 2015
From: FOX CHASE CHEMICAL DIVERSITY CENTER, INC.
To: ALS BIOPHARMA LLC
Reel/Frame 036322/0039 →
Assignment of Assignor's Interest
Aug 13, 2015
From: ALS BIOPHARMA LLC
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 036322/0078 →
Assignment of Assignor's Interest
Jan 31, 2017
From: WROBEL, JAY EDWARD; REITZ, ALLEN B.; PELLETIER, JEFFERY CLAUDE; SMITH, GARRY ROBERT
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 041131/0289 →
Assignment of Assignor's Interest
Jan 31, 2017
From: WROBEL, JAY EDWARD; REITZ, ALLEN B.; PELLETIER, JEFFERY CLAUDE; SMITH, GARRY ROBERT
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 041131/0429 →
Assignment of Assignor's Interest
Jan 31, 2017
From: PELLETIER, JEFFERY C.; WROBEL, JAY E.; REITZ, ALLEN B.
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 041566/0976 →
Assignment of Assignor's Interest
Sep 28, 2017
From: PELLETIER, JEFFERY CLAUDE; WROBEL, JAY EDWARD; REITZ, ALLEN B.
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 043721/0644 →
Assignment of Assignor's Interest
Oct 24, 2017
From: WROBEL, JAY EDWARD; REITZ, ALLEN B.; PELLETIER, JEFFERY CLAUDE; SMITH, GARRY ROBERT
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 043928/0565 →
Assignment of Assignor's Interest
Oct 24, 2017
From: WROBEL, JAY EDWARD; REITZ, ALLEN B.; PELLETIER, JEFFERY CLAUDE; SMITH, GARRY ROBERT
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 043928/0551 →
Assignment of Assignor's Interest
Jan 7, 2018
From: CORIC, VLADIMIR; BERMAN, ROBERT
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 044553/0311 →
Assignment of Assignor's Interest
Oct 16, 2019
From: BIAN, HAIYAN
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 050724/0114 →
Assignment of Assignor's Interest
Oct 19, 2019
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 050768/0383 →
Assignment of Assignor's Interest
May 11, 2020
From: PELLETIER, JEFFERY CLAUDE; WROBEL, JAY EDWARD; REITZ, ALLEN B.
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 052622/0288 →
Assignment of Assignor's Interest
May 12, 2020
From: WROBEL, JAY EDWARD; REITZ, ALLEN B.; PELLETIER, JEFFERY CLAUDE; SMITH, GARRY ROBERT
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 052636/0119 →
Assignment of Assignor's Interest
May 12, 2020
From: WROBEL, JAY EDWARD; REITZ, ALLEN B.; PELLETIER, JEFFERY CLAUDE; SMITH, GARRY ROBERT
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 052635/0954 →
Assignment of Assignor's Interest
May 12, 2020
From: CORIC, VLADIMIR
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 052635/0834 →
Assignment of Assignor's Interest
Aug 5, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053403/0828 →
Assignment of Assignor's Interest
Aug 5, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053403/0645 →
Assignment of Assignor's Interest
Aug 5, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053403/0933 →
Assignment of Assignor's Interest
Aug 5, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053403/0974 →
Assignment of Assignor's Interest
Aug 5, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053403/0696 →
Patent Security Agreement
Aug 7, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.; BIOHAVEN THERAPEUTICS LTD; BIOHAVEN PHARMACEUTICAL IRELAND DESIGNATED ACTIVITY COMPANY
To: SIXTH STREET SPECIALTY LENDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 053428/0001 →
Assignment of Assignor's Interest
Aug 7, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053429/0159 →
Assignment of Assignor's Interest
Aug 7, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053429/0276 →
Assignment of Assignor's Interest
Aug 7, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053430/0032 →
Patent Security Agreement
Dec 2, 2021
From: BIOHAVEN THERAPEUTICS LTD.
To: SIXTH STREET SPECIALTY LENDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 058299/0273 →